Abbott Laboratories
A healthcare company making everything from infant formula (Similac) and adult nutrition shakes (Ensure) to the FreeStyle Libre continuous glucose monitor and heart devices like the MitraClip. It was founded in 1888 by Chicago physician Dr. Wallace C. Abbott, who made tiny, precisely dosed pills from plant alkaloids in the back of his drugstore; the company was renamed Abbott Laboratories in 1915. Similac's name comes from "similar to lactation," its original purpose as a breast-milk substitute.
Granted 5.8K · Bought 20.0K · Sold 50.0K
Granted 1.04M · Bought 18.8K · Sold 825.9K
Granted 34.6K · Sold 10.1K
Granted 380.6K · Sold 348.1K
Granted 77.6K · Sold 25.6K
Granted 2.3K
Granted 35.2K · Sold 2.1K
Granted 154.5K · Sold 114.9K
Granted 76.1K · Bought 2.2K · Sold 5.5K
Granted 18.5K
Granted 38.0K · Sold 5.7K
Granted 96.0K · Sold 70.9K
Granted 5.8K
Granted 3.5K
Granted 10.9K · Sold 2.9K
Granted 18.8K · Sold 263
Granted 13.3K
Granted 5.8K · Sold 2.6K
Granted 14.3K · Sold 1.6K
Granted 5.8K · Bought 2.0K
Granted 5.8K
Granted 5.8K
Granted 5.8K
Granted 5.8K
Granted 5.8K
Granted 5.8K
Granted 2.3K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Starks Daniel JDirector · 8 transactions | -0.8% | 6.75M | 5.8K | 20.0K | 50.0K |
| Ford Robert BCHAIRMAN AND CEO, Director · 17 transactions | +38% | 522.7K | 1.04M | 18.8K | 825.9K |
| Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENT · 7 transactions | +5.5% | 260.7Kas of May 2024 | 34.6K | — | 10.1K |
| Allen Hubert LEXECUTIVE VICE PRESIDENT, GC · 13 transactions | +9.1% | 191.9Kas of Feb 2025 | 380.6K | — | 348.1K |
| Salvadori Daniel Gesua SiveEVP AND GROUP PRESIDENT · 11 transactions | +22.1% | 146.4K | 77.6K | — | 25.6K |
| Conroy Kevin TDirector · 1 transaction | — | 131.5K | 2.3K | — | — |
| Moreland Mary KEXECUTIVE VICE PRESIDENT · 10 transactions | +23.4% | 121.5K | 35.2K | — | 2.1K |
| Earnhardt Lisa DEVP AND GROUP PRESIDENT · 12 transactions | +19.8% | 90.4K | 154.5K | — | 114.9K |
| Boudreau Philip PEVP AND CFO · 12 transactions | — | 82.6K | 76.1K | 2.2K | 5.5K |
| Scoggins Christopher JEXECUTIVE VICE PRESIDENT · 2 transactions | +67.2% | 77.1K | 18.5K | — | — |
| Morrone Louis H.EXECUTIVE VICE PRESIDENT · 13 transactions | +33.9% | 76.9K | 38.0K | — | 5.7K |
| Wainer Andrea FRETIRED EVP · 13 transactions | +14.4% | 74.4Kas of Mar 2025 | 96.0K | — | 70.9K |
| McKinstry NancyDirector · 3 transactions | +16.4% | 41.0K | 5.8K | — | — |
| Alpern Robert JDirector · 2 transactions | +9.4% | 40.8Kas of Apr 2025 | 3.5K | — | — |
| Shroff EricSenior Vice President · 5 transactions | — | 39.2K | 10.9K | — | 2.9K |
| Cushman Elizabeth C.EVP, GC AND SECRETARY · 5 transactions | — | 38.0K | 18.8K | — | 263 |
| Orville Jacob ASenior Vice President · 1 transaction | — | 37.2K | 13.3K | — | — |
| Blount Sally E.Director · 4 transactions | +9.6% | 36.3K | 5.8K | — | 2.6K |
| McCoy John A. Jr.VICE PRESIDENT AND CONTROLLER · 13 transactions | — | 24.7K | 14.3K | — | 1.6K |
| Stratton John GDirector · 4 transactions | +50.1% | 23.3K | 5.8K | 2.0K | — |
| Kumbier MichelleDirector · 3 transactions | +47.4% | 18.0K | 5.8K | — | — |
| McDew Darren WDirector · 3 transactions | +84% | 12.7K | 5.8K | — | — |
| Roman Michael FDirector · 3 transactions | +116.3% | 10.8K | 5.8K | — | — |
| Gonzalez Patricia PaolaDirector · 3 transactions | +169.3% | 9.2K | 5.8K | — | — |
| Babineaux-Fontenot ClaireDirector · 3 transactions | +318.7% | 7.6K | 5.8K | — | — |
| O'Grady MichaelDirector · 3 transactions | +318.7% | 7.6K | 5.8K | — | — |
| Ahuja NitaDirector · 1 transaction | — | 2.3K | 2.3K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -1.42M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.